Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
tSCS and 5-Azacitidine for Motor Outcomes in Cerebral Palsy
NCT07433023Phase 2Recruiting
- Sponsor
- Shirley Ryan AbilityLab
- Start
- May 2026
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in cerebral palsy (CP), sponsored by Shirley Ryan AbilityLab. Started May 2026; status: recruiting.
02
Drugs
azacitidine
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT07433023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07433023.